Evidence map›Paper›PMID 31791343›Full record

ArticleHuman resources for health2019

Workforce requirements for comprehensive ischaemic stroke care in a developing country: the case of Saudi Arabia.

Fahmi Al-Senani, Mohammad Salawati, Mohammed AlJohani, Matthieu Cuche, Valeska Seguel Ravest, Simon Eggington

Open access · goldAbstract read
In one paragraph

Article in Human resources for health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. The Global Status of Occupational Therapy Workforce Research Worldwide: A Scoping Review.The American journal of occupational therapy : official publication of the American Occupational Therapy Association · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Burden of stroke in the Kingdom of Saudi Arabia: A soaring epidemic.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Fahmi Al-SenaniDepartment of Neurology, National Neurosciences Institute, King Fahad Medical City, Riyadh, Saudi Arabia.
Mohammad SalawatiDepartment of Neurology, National Neurosciences Institute, King Fahad Medical City, Riyadh, Saudi Arabia.
Mohammed AlJohaniDepartment of Neurology, National Neurosciences Institute, King Fahad Medical City, Riyadh, Saudi Arabia.
Matthieu CucheNeurovascular Health Economics and Reimbursement, Medtronic International Trading Sàrl, Tolochenaz, Switzerland.
Valeska Seguel RavestNeurovascular Health Economics and Reimbursement, Medtronic Ltd, Watford, UK.
Simon EggingtonCorporate Health Economics and Reimbursement, Medtronic International Trading Sàrl, Tolochenaz, Switzerland. simon.eggington@medtronic.com.ORCID 0000-0001-8105-4040
King Fahd Medical City · SAMedtronic (Ireland) · IEMedtronic (Switzerland) · CHMedtronic (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIschaemic stroke care requires a co-ordinated multi-disciplinary approach to optimise patient outcomes. Current care provision in Saudi Arabia is below international recommendations, and with increasing patient numbers, variable access to new therapies, and sub-optimal co-ordination of staff, the Kingdom's Ministry of Health has prioritised strategies to develop stroke care. Our objective was to use local epidemiological data to predict stroke incidence and to combine this with international staffing recommendations to estimate future staff requirements and their costs over a 10-year period.

methodsWe researched existing stroke services and staff availability within Saudi Arabia to establish current provision, undertook epidemiological modelling to predict stroke incidence, and used international staffing recommendations for acute and rehabilitation services to develop a care pathway to provide state-of-the-art stroke services. This information was used to determine the additional staff requirements, and their costs, across the Kingdom.

resultsOur research concluded that current staff numbers and services are inadequate to cope with the projected increase in the number of stroke cases. In order to provide acute and rehabilitation services which use the latest technologies, re-organisation of existing staff and services would be required, together with significant investment in new staff across several disciplines. An estimated additional 43.8 full-time equivalent stroke neurologists would be required, plus 53.5 full-time equivalent interventional neuroradiologists in addition to expansion of occupational therapy and psychology services. The total cost of additional staff over 10 years was estimated to be 862 390 778 Saudi Riyals ($229 970 874).

conclusionsProviding high-quality care for ischaemic stroke patients would involve significant investment in new staff in Saudi Arabia. Further research is required on the applicability of international staffing ratios to countries where there is a significant workforce gap. Nevertheless, this analysis provides a framework to inform stroke care planning and can be adapted to other regions or countries.

Indexed as

Developing CountriesHealth WorkforceHumansQuality of Health CareSaudi ArabiaStrokeStroke RehabilitationIschaemic strokeSaudi ArabiaStroke epidemiologyWorkforce planning

Identifiers

PMID31791343
PMCPMC6889528
OpenAlexW2992010326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.